SciELO - Scientific Electronic Library Online

 
vol.111 issue3Predischarge transcutaneous bilirubin screening reduces readmission rate for hyperbilirubinaemia in diverse South African newborns: A randomised controlled trial author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • On index processCited by Google
  • On index processSimilars in Google

Share


SAMJ: South African Medical Journal

On-line version ISSN 2078-5135
Print version ISSN 0256-9574

Abstract

MAKATINI, Z N et al. High virological failure rates in HI V-l perinatally infected children in South Africa: A retrospective cohort study. SAMJ, S. Afr. med. j. [online]. 2021, vol.111, n.3, pp.255-259. ISSN 2078-5135.  http://dx.doi.org/10.7196/samj.2021.v111i3.15221.

BACKGROUND: Large cohorts of HIV-1 perinatally infected children with long-term follow-up in developing countries are limitedOBJECTIVES: To explore rates and predictors of virological failure in a paediatric cohortMETHODS: A 10-year retrospective study was conducted from January 2004 to December 2013 to determine the incidence of and factors associated with virological failure among 1 659 HIV perinatally infected children in a public sector setting in South Africa (SA). Children aged < 17 years who initiated first-line antiretroviral therapy between 1 January 2004 and 31 December 2013 and had at least 5 years of HIV viral load measurements were eligibleRESULTS: The 1 659 children contributed 7 075 person-years of follow-up (PYFU). In the initial cohort of 2 024 children, 51.0% were male and 62.0% were aged <5 years. The incidence of virological failure was 18.7 per 100 PYFU. Virological failure was associated with male gender, death of the mother, concurrent tuberculosis treatment and World Health Organization stage IV disease. Of the 320 HIV isolates successfully amplified, 249 (77.8%) had drug resistance mutationsCONCLUSIONS: We observed high rates of virological failure and emergence of HIV drug resistance mutations. Despite gains made by SA in the treatment of HIV, such results challenge the country s ability to meet global targets of 90% viral suppression by 2020

        · text in English     · English ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License